{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:15:16Z","timestamp":1783329316251,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008028","name":"University of Wisconsin-Madison School of Medicine and Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD025225"],"award-info":[{"award-number":["S10 OD025225"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027503","name":"Center for Truth in Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201200","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:10:44Z","timestamp":1775545844000},"page":"201200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Dan","family":"Cappabianca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Toulany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Vidugiriene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Gnanasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithvik","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ayuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaovi H.","family":"Sodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201200_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ejh.14076","article-title":"CAR-T cell therapy in hematological malignancies: Where are we now and where are we heading for?","volume":"112","author":"Khan","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.omton.2026.201200_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40364-022-00434-9","article-title":"Strategies to enhance CAR-T persistence","volume":"10","author":"Liu","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.omton.2026.201200_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201200_bib4","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00432-021-03839-5","article-title":"GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and\/or recurrent neuroblastoma in pediatric patients","volume":"148","author":"Yu","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201200_bib5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fonc.2020.01000","article-title":"Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy","volume":"10","author":"Nazha","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201200_bib6","unstructured":"Neuroblastoma Survival Rates https:\/\/www.cancer.org\/cancer\/types\/neuroblastoma\/detection-diagnosis-staging\/survival-rates.html."},{"key":"10.1016\/j.omton.2026.201200_bib7","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3389\/fimmu.2018.02380","article-title":"CAR T cell therapy for neuroblastoma","volume":"9","author":"Richards","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccell.2023.11.011","article-title":"Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy","volume":"42","author":"Kaczanowska","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201200_bib9","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1038\/s41591-025-03874-6","article-title":"GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1\/2 trial","volume":"31","author":"Locatelli","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201200_bib10","article-title":"Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma","volume":"16","author":"Cao","year":"2025","journal-title":"Nat. Commun"},{"key":"10.1016\/j.omton.2026.201200_bib11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell\u2013like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201200_bib12","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201200_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","article-title":"Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response","volume":"5","author":"Gnanaprakasam","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.omton.2026.201200_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101249","article-title":"Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence","volume":"32","author":"Cappabianca","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2026.201200_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215710","article-title":"Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity","volume":"538","author":"Shen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201200_bib16","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jcyt.2019.03.348","article-title":"Glucose deprivation enriches for central memory T cells during chimeric antigen receptor-T cell expansion","volume":"21","author":"Amini","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omton.2026.201200_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009949","article-title":"Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming","volume":"12","author":"Dai","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2026.201200_bib18","article-title":"Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state","volume":"5","author":"Zhang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omton.2026.201200_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122299","article-title":"Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity","volume":"3","author":"Pilipow","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2026.201200_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114065","article-title":"Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway","volume":"43","author":"Zhu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201200_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"Gryder","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.omton.2026.201200_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","article-title":"Class II histone deacetylases: versatile regulators","volume":"19","author":"Verdin","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.omton.2026.201200_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.mcb.2021.06.014","article-title":"Generation of CAR T-cells using \u03b3-retroviral vector","volume":"167","author":"Watanabe","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.omton.2026.201200_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbiotec.2016.10.016","article-title":"Challenges of up-scaling lentivirus production and processing","volume":"240","author":"McCarron","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omton.2026.201200_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41551-019-0409-0","article-title":"Orthotopic replacement of T-cell receptor \u03b1- and \u03b2-chains with preservation of near-physiological T-cell function","volume":"3","author":"Schober","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omton.2026.201200_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004446","article-title":"Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2026.201200_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-05531-1","article-title":"Non-viral precision T cell receptor replacement for personalized cell therapy","volume":"615","author":"Foy","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201200_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/mt.2016.63","article-title":"GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade","volume":"24","author":"Gargett","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201200_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201200_bib30","first-page":"1","article-title":"Label-free metabolic imaging monitors the fitness of chimeric antigen receptor T cells","author":"Pham","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omton.2026.201200_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101437","article-title":"Efficient nonviral integration of large transgenes into human T cells using Cas9-CLIPT","volume":"33","author":"Tommasi","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2026.201200_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1379900","article-title":"Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells","volume":"12","author":"Cappabianca","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omton.2026.201200_bib33","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.3390\/ijms23147828","article-title":"Role of histone deacetylases in T-cell development and function","volume":"23","author":"Pieniawska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201200_bib34","first-page":"3791","article-title":"Long-term monitoring of oxygen consumption rates in highly differentiated and polarized retinal pigment epithelial cultures","volume":"10","author":"Zhang","year":"2024","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omton.2026.201200_bib35","first-page":"257","article-title":"Malate dehydrogenases-structure and function","volume":"21","author":"Min\u00e1rik","year":"2002","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.omton.2026.201200_bib36","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.febslet.2008.09.042","article-title":"Mitochondria and L-lactate metabolism","volume":"582","author":"Passarella","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2026.201200_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mito.2017.10.006","article-title":"Mitochondrial activity in T cells","volume":"41","author":"Desd\u00edn-Mic\u00f3","year":"2018","journal-title":"Mitochondrion"},{"key":"10.1016\/j.omton.2026.201200_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tcb.2022.05.007","article-title":"Arming a killer: mitochondrial regulation of CD8+ T cell cytotoxicity","volume":"33","author":"Lisci","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omton.2026.201200_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201200_bib40","article-title":"Epigenetically silenced DACT3 promotes tumor growth via affecting Wnt\/beta-catenin signaling and supports chidamide plus azacitidine therapy in acute myeloid leukemia","author":"Jiang","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omton.2026.201200_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110390","article-title":"A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells","volume":"129","author":"He","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2026.201200_bib42","first-page":"489","article-title":"Chidamide and venetoclax synergistically regulate the Wnt\/\u03b2-catenin pathway by MYCN\/DKK3 in B-ALL","volume":"104","author":"Zhao","year":"2025","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.omton.2026.201200_bib43","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1128\/MCB.18.8.4807","article-title":"Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin","volume":"18","author":"Hsu","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2026.201200_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003603","article-title":"\u03b2-Catenin-independent activation of TCF1\/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors","volume":"9","author":"Grumolato","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omton.2026.201200_bib45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3324\/haematol.2009.013870","article-title":"Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma","volume":"95","author":"Wozniak","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2026.201200_bib46","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.167.9.4838","article-title":"Viral infections induce abundant numbers of senescent CD8 T cells","volume":"167","author":"Voehringer","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib47","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood-2002-02-0657","article-title":"Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)","volume":"100","author":"Voehringer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201200_bib48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.179.2.1022","article-title":"Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans","volume":"179","author":"Schwartzkopff","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","article-title":"KLRG1+ effector CD8+ T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity","volume":"48","author":"Herndler-Brandstetter","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201200_bib50","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","article-title":"KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells","volume":"113","author":"Henson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201200_bib51","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/eji.200838690","article-title":"Interaction of KLRG1 with E-cadherin: new functional and structural insights","volume":"38","author":"Rosshart","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031206","article-title":"N-cadherin in neuroblastoma disease: expression and clinical significance","volume":"7","author":"Lammens","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201200_bib54","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s43018-025-01009-x","article-title":"CAR-engineered lymphocyte persistence is governed by a FAS ligand\u2013FAS autoregulatory circuit","volume":"6","author":"Yi","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omton.2026.201200_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2820","article-title":"Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL","volume":"8","author":"Bai","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omton.2026.201200_bib56","first-page":"1578","article-title":"Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4\/CCL2 signaling pathway","volume":"22","author":"Liu","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.omton.2026.201200_bib57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/or.2014.3595","article-title":"Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax\/Bcl-2 and P21 in pancreatic cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2026.201200_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166896","article-title":"Chidamide inhibits aerobic metabolism to induce pancreatic cancer cell growth arrest by promoting Mcl-1 degradation","volume":"11","author":"He","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201200_bib59","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/febs.15456","article-title":"HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle","volume":"288","author":"Hurtado","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.omton.2026.201200_bib60","doi-asserted-by":"crossref","first-page":"E2592","DOI":"10.1073\/pnas.1300113110","article-title":"Histone deacetylase 10 promotes autophagy-mediated cell survival","volume":"110","author":"Oehme","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201200_bib61","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e9","article-title":"Metabolic challenges in anticancer CD8 T cell functions","volume":"23","author":"Amitrano","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.omton.2026.201200_bib62","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/s41467-024-46377-7","article-title":"Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors","volume":"15","author":"Simula","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201200_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf7579","article-title":"Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8+ T cell formation","volume":"8","author":"Franco","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib64","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4049\/jimmunol.1001822","article-title":"Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes","volume":"186","author":"Jia","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201200_bib65","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1038\/s41598-018-25295-x","article-title":"Reduced autophagy by a microRNA-mediated signaling cascade in diabetes-induced renal glomerular hypertrophy","volume":"8","author":"Deshpande","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201200_bib66","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1182\/blood-2023-189441","article-title":"Autophagy inhibition prevents CAR-T exhaustion and terminal differentiation via TCF7 accumulation","volume":"142","author":"Teng","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201200_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2004.11.008","article-title":"Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS","volume":"74","author":"Toulany","year":"2005","journal-title":"Radiother. Oncol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:19:50Z","timestamp":1783325990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000767"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201200","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201200"}}